EE200000767A - Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon - Google Patents

Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon

Info

Publication number
EE200000767A
EE200000767A EEP200000767A EEP200000767A EE200000767A EE 200000767 A EE200000767 A EE 200000767A EE P200000767 A EEP200000767 A EE P200000767A EE P200000767 A EEP200000767 A EE P200000767A EE 200000767 A EE200000767 A EE 200000767A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
triazolopyridazine derivative
substituted triazolopyridazine
substituted
Prior art date
Application number
EEP200000767A
Other languages
English (en)
Estonian (et)
Inventor
Robert Carling William
Joseph Street Leslie
Luis Castro Pineiro Jose
John Cowden Cameron
John Davies Antony
Madin Andrew
Francis Mccabe James
Edward Stephen Pearce Gareth
Original Assignee
Merck Sharp & Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited
Publication of EE200000767A publication Critical patent/EE200000767A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000767A 1998-06-24 1999-06-15 Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon EE200000767A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9813576.7A GB9813576D0 (en) 1998-06-24 1998-06-24 Therapeutic agents
PCT/GB1999/001897 WO1999067245A1 (en) 1998-06-24 1999-06-15 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom

Publications (1)

Publication Number Publication Date
EE200000767A true EE200000767A (et) 2002-06-17

Family

ID=10834265

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000767A EE200000767A (et) 1998-06-24 1999-06-15 Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon

Country Status (35)

Country Link
US (1) US6630471B1 (cs)
EP (1) EP1090004B1 (cs)
JP (1) JP4749545B2 (cs)
KR (1) KR100604108B1 (cs)
CN (1) CN1138779C (cs)
AR (1) AR018925A1 (cs)
AT (1) ATE239730T1 (cs)
AU (1) AU757315B2 (cs)
BG (1) BG64989B1 (cs)
BR (1) BR9911563A (cs)
CA (1) CA2335328C (cs)
CO (1) CO5031239A1 (cs)
CZ (1) CZ291409B6 (cs)
DE (1) DE69907675T2 (cs)
EA (1) EA003332B1 (cs)
EE (1) EE200000767A (cs)
ES (1) ES2196824T3 (cs)
GB (1) GB9813576D0 (cs)
GE (1) GEP20033143B (cs)
HR (1) HRP20000879A2 (cs)
HU (1) HUP0102894A3 (cs)
ID (1) ID27771A (cs)
IL (2) IL139775A0 (cs)
IS (1) IS2258B (cs)
MY (1) MY124341A (cs)
NO (1) NO317992B1 (cs)
NZ (1) NZ508290A (cs)
PE (1) PE20000710A1 (cs)
PL (1) PL204650B1 (cs)
RS (1) RS49746B (cs)
SK (1) SK285307B6 (cs)
TR (1) TR200003789T2 (cs)
TW (1) TWI222449B (cs)
WO (1) WO1999067245A1 (cs)
ZA (1) ZA200007485B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345443A (en) * 1999-01-08 2000-07-12 Merck Sharp & Dohme Use of triazolo-pyridazines for treating premenstrual syndrome
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
GB0111191D0 (en) * 2001-05-08 2001-06-27 Merck Sharp & Dohme Therapeutic agents
KR101075812B1 (ko) 2002-12-18 2011-10-25 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로서의 트리아졸로피리다진
WO2006061428A2 (en) * 2004-12-10 2006-06-15 Universität Zürich Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
EP2454259A1 (en) 2009-06-23 2012-05-23 Concert Pharmaceuticals Inc. Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
US20110082147A1 (en) * 2009-07-24 2011-04-07 Concert Pharmaceuticals, Inc. Substituted imidazotriazines
US8278460B2 (en) 2009-10-15 2012-10-02 Concert Pharmaceuticals, Inc. Substituted benzimidazoles
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en) * 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
US9586963B2 (en) 2011-09-27 2017-03-07 Genfit Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
AU2017213154B2 (en) 2016-01-27 2023-02-02 Universität Zürich Use of GABAA receptor modulators for treatment of itch
WO2019204446A1 (en) 2018-04-18 2019-10-24 Neurocycle Therapeutics, Inc. Gabaa positive allosteric modulator compounds, methods of making, and uses thereof
EA202190717A1 (ru) * 2018-09-13 2021-09-22 Саниона А/С Лиганд рецептора гамк-а
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
US20240043418A1 (en) 2020-03-26 2024-02-08 Richter Gedeon Nyrt. 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators
WO2025141131A1 (en) 2023-12-27 2025-07-03 Saniona A/S A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004559A2 (en) 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited Substituted triazolo-pyridazine derivatives as ligands for gaba receptors

Also Published As

Publication number Publication date
CZ20004872A3 (cs) 2001-07-11
US6630471B1 (en) 2003-10-07
CO5031239A1 (es) 2001-04-27
DE69907675D1 (de) 2003-06-12
TWI222449B (en) 2004-10-21
HUP0102894A3 (en) 2003-03-28
EA200100071A1 (ru) 2001-06-25
IL139775A0 (en) 2002-02-10
AU757315B2 (en) 2003-02-13
CN1307579A (zh) 2001-08-08
HRP20000879A2 (en) 2001-06-30
CA2335328A1 (en) 1999-12-29
NO20006576L (no) 2001-02-14
HUP0102894A2 (hu) 2001-11-28
ID27771A (id) 2001-04-26
NO20006576D0 (no) 2000-12-21
SK285307B6 (sk) 2006-10-05
KR100604108B1 (ko) 2006-07-26
PL345332A1 (en) 2001-12-17
JP4749545B2 (ja) 2011-08-17
AU4630199A (en) 2000-01-10
EP1090004A1 (en) 2001-04-11
IL139775A (en) 2007-02-11
GB9813576D0 (en) 1998-08-19
CN1138779C (zh) 2004-02-18
ES2196824T3 (es) 2003-12-16
WO1999067245A1 (en) 1999-12-29
NZ508290A (en) 2003-09-26
BG64989B1 (bg) 2006-11-30
BG105152A (en) 2001-10-31
CA2335328C (en) 2007-11-27
TR200003789T2 (tr) 2001-04-20
CZ291409B6 (cs) 2003-03-12
JP2002518501A (ja) 2002-06-25
IS5730A (is) 2000-11-24
KR20010053136A (ko) 2001-06-25
PL204650B1 (pl) 2010-01-29
ZA200007485B (en) 2002-01-07
YU77800A (sh) 2003-10-31
EP1090004B1 (en) 2003-05-07
IS2258B (is) 2007-06-15
RS49746B (sr) 2008-04-04
EA003332B1 (ru) 2003-04-24
ATE239730T1 (de) 2003-05-15
BR9911563A (pt) 2001-03-20
PE20000710A1 (es) 2000-08-14
NO317992B1 (no) 2005-01-17
MY124341A (en) 2006-06-30
DE69907675T2 (de) 2004-03-04
SK19552000A3 (sk) 2001-08-06
AR018925A1 (es) 2001-12-12
GEP20033143B (en) 2003-12-25

Similar Documents

Publication Publication Date Title
EE200000596A (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
EE05214B1 (et) Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE05086B1 (et) Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200200017A (et) Kinuklidiinderivaadid, nende valmistamismeetod, vaheühendid, farmatseutiline kompositsioon ja nendekasutamine
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200000767A (et) Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE200000620A (et) 3-(amino- või aminoalküül)püridinooni derivaadid,nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE200200298A (et) Asendatud ftalotsüaniinid ja nende lähteühendid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja materjal
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE03691B1 (et) 1,2,3,4-tetrahüdrobensofuro[3,4-c]püridiini derivaadid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE04914B1 (et) Eletriptaanvesinikbromiidi monohüdraat, selle kasutamine ja protsess selle valmistamiseks ning eletriptaanvesinikbromiidi monohüdraati sisaldav farmatseutiline kompositsioon
EE04812B1 (et) 2-fenüülpüraan-4-ooni derivaadid, nende valmistamismeetod ja kasutamine, vaheühendite kasutamine jafarmatseutiline kompositsioon
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat